PhRMA Pushes Cost Savings Of Novel Drugs In Japan, Just As New Prices Announced
This article was originally published in PharmAsia News
Executive Summary
Celgene CEO Robert Hugin outlined cost effectiveness of new drugs and met with Japan’s prime minister in his first overseas trip as the new chairman of PhRMA.